InnoVero and Tasso Extend Partnership Providing Athlete-Centric Solutions for Anti-Doping Testing
09 Julio 2024 - 8:00AM
Business Wire
Industry innovators will continue collaborating on virtually
painless, secure anti-doping technologies
InnoVero, a global leader in providing innovative,
athlete-centric collection technologies to anti-doping
organizations worldwide and Tasso, Inc., the leading provider of
patient-centric, clinical grade blood collection solutions, today
announced the extension of their partnership that was first
initiated in 2021. In addition to collaboratively developing new
athlete-centric solutions, InnoVero will continue to serve as the
exclusive worldwide distributor of Tasso blood collection solutions
for the anti-doping marketplace.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240709568493/en/
As part of the InnoVero SAFESystem™ product suite, the companies
have co-developed a secure, intuitive, and virtually painless
system for anti-doping blood testing. The system features Tasso’s
signature capillary blood collection technology, which frees
athletes from the inconvenience of traditional blood tests such as
venipuncture or fingerstick collections. The combined offering,
which has been well-received by key stakeholders, including
athletes, doping control officers, administrators, and
laboratories, continues to see expanded utilization across
anti-doping testing programs globally. Professional and Olympic and
Paralympic sports organizations, as well as major international
sporting events, such as the upcoming Paris 2024 Olympic Games,
have quickly realized the advantages of this athlete-centric
technology.
“Our partnership with Tasso is helping us deliver on our promise
to drive innovation and integrity in anti-doping products. Tasso’s
signature capillary blood collection technology has significantly
improved the blood collection process providing an efficient,
easy-to-implement, and athletic-centric solution,” said Gabe Baida,
Executive Director of InnoVero. “The response to our Tasso-based
collection system from athletes and anti-doping organizations has
been very positive. We are pleased to extend our partnership with
Tasso and excited to continue developing innovative solutions
together at the forefront of anti-doping technology.”
“The extension of our partnership with InnoVero demonstrates the
strong demand for athlete-centric solutions,” said Ben Casavant,
PhD, CEO and Co-Founder of Tasso. “Tasso’s virtually painless blood
collection technology, combined with InnoVero’s leading security
innovations, empowers athletes to focus on their performance and
trust in a level playing field. Together, InnoVero and Tasso will
continue to improve anti-doping testing for athletes
everywhere.”
About InnoVero
InnoVero provides innovation and integrity to the global
anti-doping community, through solutions designed to secure global
athlete trust. InnoVero’s SAFESystem™ sample collection solutions
serve clients globally, The SAFESystem™ features revolutionary
security mechanisms that ensure its sample collection bottles are
secure, athlete-friendly and tamper-evident, among a suite of
features designed to provide seamless and efficient use by
athletes, doping control officers and laboratories. For more
information about InnoVero, please visit
www.innoveroglobal.com.
About Tasso
Tasso is an emerging healthcare technology company that is
transforming the traditional blood collection paradigm with a
patient-centric approach. The company’s devices enable simple,
convenient, and virtually painless blood collection for users.
Tasso technology has the power to bring healthcare anywhere, any
time. Headquartered in Seattle, Washington, Tasso is privately held
and funded by grants, investments, and co-development deals with
various industry leaders. For more information, please visit
www.tassoinc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240709568493/en/
InnoVero Brad Horn (512) 636-3831 bhorn@innoveroglobal.com
Tasso, Inc. Dina Schneider (206) 822-4186 x1016
media@tassoinc.com